Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 3895-3902

  Zhuo, Jia Min ^a   Pratico, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid ; APP metabolism; Fear conditioning test

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HOMOCYSTEINE; METHIONINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN AMYLOIDOSIS; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; FEMALE; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; HUMAN; METABOLISM; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

AMYLOIDOSIS; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; HYPERHOMOCYSTEINEMIA; MICE; MICE, TRANSGENIC;

EID: 77957848546     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-161828     Document Type: Article

References (41)

1. Morris, M. S. (2003) Homocysteine and Alzheimer's disease. Lancet Neurol. 2, 425-428
2. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., and Ueland, P. M. (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 55, 1449-1455
3. Gottfries, C. G., Lehmann, W., and Regland, B. (1998) Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease. J. Neural Transm. 105, 773-786 (Pubitemid 28539829)
4. Morris, M. S., Jacques, P. F., Rosenberg, I. H., and Selhub, J. (2001) Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 73, 927-933 (Pubitemid 32405990)
5. McCaddon, A., Davies, G., Hudson, P., Tandy, S., and Cattell, H. (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13, 235-239 (Pubitemid 28194997)
6. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W., and Wolf, P. A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483
7. Seshadri, S. (2006) Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J. Alzheimers Dis. 9, 393-398
8. Suszynska, J., Tisonczyk, J., Lee, H. G., Smith, M. A., and Jakubowski, H. (2010) Reduced homocysteine-thiolactonase activity in Alzheimer's disease. J. Alzheimers Dis. 19, 1177-1183
9. Troen, A. M., Shea-Budgell, M., Shukitt-Hale, B., Smith, D. E., Selhub, J., and Rosenberg, I. H. (2008) B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl. Acad. Sci. U. S. A. 105, 12474-12479
10. Jacobsen, D. W. (2000) Hyperhomocysteinemia and oxidative stress: time for a reality check? Arterioscler. Thromb. Vasc. Biol. 20, 1182-1184
11. Fuso, A., Seminara, L., Cavallaro, R. A., D'Anselmi, F., and Scarpa, S. (2005) S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell Neurosci. 28, 195-204 (Pubitemid 39656023)
12. Kruman, II, Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N., Lee, J., Evans, M., and Mattson, M. P. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762
13. Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'Emilia, D. M., Rayudu, P. V., Arnelle, D. R., and Stamler, J. S. (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 94, 5923-5928 (Pubitemid 27241873)
14. Boldyrev, A. A., and Johnson, P. (2007) Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. J. Alzheimers Dis. 11, 219-228
15. Zhuo, J. M., Portugal, G. S., Kruger, W. D., Wang, H., Gould, T. J., and Pratico, D. (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr. Alzheimer Res. 7, 140-149
16. Fuso, A., Nicolia, V., Cavallaro, R. A., Ricceri, L., D'Anselmi, F., Coluccia, P., Calamandrei, G., and Scarpa, S. (2008) B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell Neurosci. 37, 731-746
17. Zhang, C. E., Wei, W., Liu, Y. H., Peng, J. H., Tian, Q., Liu, G. P., Zhang, Y., and Wang, J. Z. (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174, 1481-1491
18. Zhuo, J. M., and Pratico, D. (2010) Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp. Gerontol. 45, 195-201
19. Balk, E. M., Raman, G., Tatsioni, A., Chung, M., Lau, J., and Rosenberg, I. H. (2007) Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch. Intern. Med. 167, 21-30
20. Van Dam, F., and Van Gool, W. A. (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch. Gerontol. Geriatr. 48, 425-430
21. Sommer, B. R., Hoff, A. L., and Costa, M. (2003) Folic acid supplementation in dementia: a preliminary report. J. Geriatr. Psychiatry Neurol. 16, 156-159
22. Bryan, J., Calvaresi, E., and Hughes, D. (2002) Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J. Nutr. 132, 1345-1356 (Pubitemid 34606475)
23. Hvas, A. M., Juul, S., Lauritzen, L., Nexo, E., and Ellegaard, J. (2004) No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J. Affect Disord. 81, 269-273
24. Pratico, D. (2009) High-dose B vitamin supplements and Alzheimer disease. JAMA 301, 1020-1021; author reply 1021-1022
25. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102
26. Hofmann, M. A., Lalla, E., Lu, Y., Gleason, M. R., Wolf, B. M., Tanji, N., Ferran, L. J., Jr., Kohl, B., Rao, V., Kisiel, W., Stern, D. M., and Schmidt, A. M. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107, 675-683
27. Poirier, R., Cheval, H., Mailhes, C., Charnay, P., Davis, S., and Laroche, S. (2007) Paradoxical role of an Egr transcription factor family member, Egr2/Krox20, in learning and memory. Front Behav. Neurosci. 1, 6
28. Firuzi, O., Zhuo, J., Chinnici, C. M., Wisniewski, T., and Pratico, D. (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. FASEB J. 22, 1169-1178 (Pubitemid 351519971)
29. Sung, S., Yang, H., Uryu, K., Lee, E. B., Zhao, L., Shineman, D., Trojanowski, J. Q., Lee, V. M., and Pratico, D. (2004) Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165, 2197-2206
30. Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., and Selkoe, D. J. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40, 1087-1093
31. Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q., and Lee, V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183-4187
32. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P. R., Rimmer, E., and Scazufca, M. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117
33. Herrmann, N. (2002) Cognitive pharmacotherapy of Alzheimer's disease and other dementias. Can. J. Psychiatry 47, 715-722 (Pubitemid 35345715)
34. Jakubowski, H., Perla-Kajan, J., Finnell, R. H., Cabrera, R. M., Wang, H., Gupta, S., Kruger, W. D., Kraus, J. P., and Shih, D. M. (2009) Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 23, 1721-1727
35. Maren, S. (2001) Neurobiology of Pavlovian fear conditioning. Annu. Rev. Neurosci. 24, 897-931
36. Jope, R. S., and Johnson, G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102
37. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid- beta peptides. Nature 423, 435-439
38. Pratico, D. (2008) Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharm. Sci. 29, 609-615
39. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F., Bottiglieri, T., Jin, S., Stokes, K. T., Thomas, R. G., and Thal, L. J. (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783
40. Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., and Verhoef, P. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369, 208-216
41. Nilsson, K., Gustafson, L., and Hultberg, B. (2001) Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int. J. Geriatr. Psychiat. 16, 609-614 (Pubitemid 32618854)